Name | fenclorim |
---|---|
Synonyms |
2-Phenyl-4,6-dichloropyrimidine
MFCD00754193 fenclorim 4,6-Dichloro-2-phenylpyrimidine T6N CNJ BR& DG FG Pyrimidine, 4,6-dichloro-2-phenyl- |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 235.5±33.0 °C at 760 mmHg |
Melting Point | 92-93ºC |
Molecular Formula | C10H6Cl2N2 |
Molecular Weight | 225.074 |
Flash Point | 118.9±11.0 °C |
Exact Mass | 223.990799 |
PSA | 25.78000 |
LogP | 4.02 |
Vapour Pressure | 0.1±0.4 mmHg at 25°C |
Index of Refraction | 1.605 |
Storage condition | Refrigerator |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H317-H318-H332 |
Precautionary Statements | P280-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn:Harmful; |
Risk Phrases | R20;R43 |
Safety Phrases | S36/37 |
RIDADR | UN 3077 |
RTECS | UV8258400 |
Packaging Group | III |
HS Code | 2933599090 |
~95% 3740-92-9 |
Literature: Castelhano, Arlindo; McKibben, Bryan; Steinig, Arno; Collington, Eric Patent: US2003/162764 A1, 2003 ; US 20030162764 A1 |
~33% 3740-92-9 |
Literature: MIIKANA THERAPEUTICS, INC. Patent: WO2008/154026 A1, 2008 ; Location in patent: Page/Page column 88 ; WO 2008/154026 A1 |
~% 3740-92-9 |
Literature: Harden, Donald B.; Mokrosz, Maria J.; Strekowski, Lucjan Journal of Organic Chemistry, 1988 , vol. 53, # 17 p. 4137 - 4140 |
~68% 3740-92-9 |
Literature: Lee, Hong Woo; Bok, Young Kim; Joong, Bok Ahn; Sung, Kwon Kang; Lee, Jung Hwa; Jae, Soo Shin; Soon, Kil Ahn; Lee, Sang Joon; Seung, Soo Yoon European Journal of Medicinal Chemistry, 2005 , vol. 40, # 9 p. 862 - 874 |
~% 3740-92-9 |
Literature: Biagi; Giorgi; Livi; Scartoni; Lucacchini Farmaco, 1997 , vol. 52, # 1 p. 61 - 65 |
~% 3740-92-9 |
Literature: Hendry; Homer Journal of the Chemical Society, 1952 , p. 328,333 |
Precursor 9 | |
---|---|
DownStream 8 | |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |